APOE and Alzheimer disease: Apolipoprotein E4 (APOE4) is the strongest genetic risk factor associated with late-onset AD among the three polymorphic alleles (APOE2, APOE3, and APOE4), and has recently been proposed to impair myelination via cholesterol dysregulation in oligodendrocytes [106, 107].